SMYD3 and hyperlipidemia: Some researchers have established cellular and animal models to study the effects of chitosan on hyperlipidemia and have shown that chitosan considerably reduced lipid accumulation in HepG2 cells and the expression of HMGCR, SET and MYND domain containing 3 (SMYD3) in animal models [104].